Efficacy and Safety Evaluation of Levocarnitine Combined with Recombinant Human Erythropoietin in the Treatment of Hemodialysis Patients with Renal Anemia

XU Xiaoman; CHEN Ruwu; XU Danxia

doi:10.14033/j.cnki.cfmr.2021.19.006

Home>Articles>Efficacy and Safety Evaluation of Levocarnitine Combined with Recombinant Human Erythropoietin in the Treatment of Hemodialysis Patients with Renal Anemia

DOI: 10.14033/j.cnki.cfmr.2021.19.006

Efficacy and Safety Evaluation of Levocarnitine Combined with Recombinant Human Erythropoietin in the Treatment of Hemodialysis Patients with Renal Anemia

XU Xiaoman

CHEN Ruwu

XU Danxia

Machine-generated Keywords：

Publication Date：2021-07-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 16-18 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2021,19(19)